Breaking News Instant updates and real-time market news.

RMBS

Rambus

$12.04

0.16 (1.35%)

, SFTBF

SoftBank

$75.41

-1.08 (-1.41%)

16:32
05/18/17
05/18
16:32
05/18/17
16:32

Rambus partners with Cybertrust to secure connected devices

Rambus (RMBS) announced a partnership with Cybertrust Japan, a provider of public key infrastructure solutions and a subsidiary of SoftBank (SFTBF) Technology, to deliver secure key provisioning and security services for connected devices spanning from enterprise multi-function printers to connected cars. "This collaboration combines the Rambus CryptoManager Infrastructure, a secure provisioning and key management system, and the Cybertrust PKI solution, to secure communication from device-to-cloud and for over-the-air software updates. The joint solution brings two leading security providers together to deliver a turn-key platform that addresses the increasingly complex security challenges for connected devices," the company said.

RMBS

Rambus

$12.04

0.16 (1.35%)

SFTBF

SoftBank

$75.41

-1.08 (-1.41%)

  • 22

    May

  • 13

    Jun

RMBS Rambus
$12.04

0.16 (1.35%)

01/31/17
LOOP
01/31/17
NO CHANGE
Target $16
LOOP
Buy
Rambus weakness on purchase accounting concerns overdone, says Loop Capital
Loop Capital analyst Betsy Van Hees attributes the weakness in shares of Rambus following its "solid" results and guidance is attributable to worries over its purchase accounting impairment charge of $18.3M for in-process R&D. However, she believes that the weakness is overdone given the company's growth opportunities in 2017 and the fact that a large portion of its royalty and licensing revenue is fixed and committed long-term. Van Hees keeps a Buy rating and $16 price target on Rambus shares.
02/09/17
JPMS
02/09/17
UPGRADE
Target $14.5
JPMS
Overweight
Rambus upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Paul Coster upgraded Rambus to Overweight saying the 10% pullback in shares since the company's Q4 results presents a buying opportunity. The licensing business provides some downside protection while investments in disruptive data center/cloud service and mobile-edge technologies provides "plenty of upside potential," Coster tells investors in a research note. He has a $14.50 price target for the shares.
03/07/17
JPMS
03/07/17
NO CHANGE
Target $14.5
JPMS
Overweight
Rambus added to Analyst Focus List at JPMorgan
JPMorgan analyst Paul Coster added Rambus to his firm's U.S. Analyst Focus List as a near-term long idea. The 8.5% pullback since the company's Q4 results provides opportunity to buy this stock at a reasonable price, Coster tells investors in a research note. He sees good near-term revenue and earnings visibility and keeps an Overweight rating on Rambus with a $14.50 price target.
03/07/17
BNCH
03/07/17
NO CHANGE
Target $15
BNCH
Buy
Rambus license pact with Western Digital 'unique and intriguing,' says Benchmark
Benchmark analyst Gary Mobley called Rambus' (RMBS) newly-announced license agreement with Western Digital (WDC) "unique and intriguing," noting that Rambus memory patent licensing has historically been within the DRAM industry, not the NAND flash market. He believes the underpinnings of the agreement may relate to Rambus' ReRAM IP portfolio, and also finds it "interesting to note" that the agreement includes Rambus' security IP. Mobley has a Buy rating and $15 price target on Rambus shares.
SFTBF SoftBank
$75.41

-1.08 (-1.41%)

08/23/16
JPMS
08/23/16
UPGRADE
JPMS
Overweight
SoftBank upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jun Tanabe upgraded SoftBank (SFTBF) to Overweight from Neutral and raised his price target on the stock to Y9,930 from Y6,500, citing improved earnings at Sprint (S), the growth in value of its stake in Alibaba (BABA), and the stability of cash flow in its domestic mobile business.
08/23/16
08/23/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying he now feels more confident in the company's growth and profitability outlook and its competitive position following three quarters of consistent execution. 2. BHP Billiton (BHP) upgraded to Buy from Hold at Jefferies with analyst Christopher LaFemina saying he believes fundamentals have "clearly improved," citing supply that has declined in most cases and demand that has stabilized. 3. SoftBank (SFTBF) upgraded to Overweight from Neutral at JPMorgan with analyst Jun Tanabe citing improved earnings at Sprint (S), the growth in value of its stake in Alibaba (BABA), and the stability of cash flow in its domestic mobile business. 4. Allscripts (MDRX) upgraded to Outperform from Market Perform at Leerink with analyst David Larsen saying he believes that the company's core fundamentals are improving "significantly." 5. Westlake Chemical (WLK) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying that the company's merger with Axiall (AXLL) "creates a new way to play chlor-alkali," as well as synergies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/07/16
OPCO
12/07/16
NO CHANGE
Target $70
OPCO
Outperform
T-Mobile price target raised to $70 from $55 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for T-Mobile (TMUS) to $70 from $55 as he views it as the best way to play the deregulatory/technology driven consolidation. The analyst notes that President-Elect Trump met with Masayoshi Son of SoftBank (SFTBF), who agreed to invest $50B in the U.S. Horan believes the meeting will likely be a precursor to a Sprint (S)/T-Mobile/Dish (DISH) merger to create a discounted quad-play service company. The analyst reiterates an Outperform rating on T-Mobile' shares, and points out that the company has improved its network and taken share from AT&T (T)/Verizon (VZ).

TODAY'S FREE FLY STORIES

FIT

Fitbit

$5.61

-0.15 (-2.60%)

08:45
07/24/17
07/24
08:45
07/24/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SPI

SPI Energy

$0.54

-0.047 (-8.01%)

08:44
07/24/17
07/24
08:44
07/24/17
08:44
Hot Stocks
SPI Energy says Nasdaq grants request to extend stay of suspension in trading »

SPI Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBIO

iBio

$0.32

-0.006 (-1.82%)

08:43
07/24/17
07/24
08:43
07/24/17
08:43
Hot Stocks
iBio enters into stock purchase agreement for up to $16M with LPC »

iBio announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$1.11

-0.01 (-0.89%)

08:43
07/24/17
07/24
08:43
07/24/17
08:43
Conference/Events
Cytori Therapeutics to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOH

Bank of Hawaii

$81.45

-0.52 (-0.63%)

08:42
07/24/17
07/24
08:42
07/24/17
08:42
Earnings
Bank of Hawaii reports Q2 EPS $1.05, consensus $1.03 »

Loan and lease balances…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JCP

J.C. Penney

$5.08

0.08 (1.60%)

, AAPL

Apple

$150.27

-0.07 (-0.05%)

08:40
07/24/17
07/24
08:40
07/24/17
08:40
Hot Stocks
J.C. Penney now accepts Apple Pay at all stores »

JCPenney (JCP) has rolled…

JCP

J.C. Penney

$5.08

0.08 (1.60%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

WWD

Woodward

$68.55

-0.87 (-1.25%)

08:39
07/24/17
07/24
08:39
07/24/17
08:39
Conference/Events
Woodward management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 31

    Jul

SILC

Silicom

$51.37

0.96 (1.90%)

08:38
07/24/17
07/24
08:38
07/24/17
08:38
Conference/Events
Silicom management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

OTIV

On Track Innovations

$1.47

0.025 (1.74%)

08:38
07/24/17
07/24
08:38
07/24/17
08:38
Hot Stocks
On Track Innovations' Uno-8 contactless reader granted EMVCo Modular approval »

On Track Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

FNJN

Finjan Holdings

08:38
07/24/17
07/24
08:38
07/24/17
08:38
Hot Stocks
Finjan Holdings says oral arguments to be heard at Court of Appeals on Sep. 8 »

Finjan Holdings (FNJN),…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POL

PolyOne

$38.46

-0.18 (-0.47%)

08:37
07/24/17
07/24
08:37
07/24/17
08:37
Conference/Events
PolyOne management to meet with Northcoast »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 31

    Jul

  • 01

    Aug

ARNC

Arconic

$25.21

0.46 (1.86%)

08:37
07/24/17
07/24
08:37
07/24/17
08:37
Earnings
Arconic sees FY17 EPS $1.15-$1.20, consensus $1.16 »

The company adjusted 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HIFR

InfraREIT

$19.90

0.2 (1.02%)

08:37
07/24/17
07/24
08:37
07/24/17
08:37
Hot Stocks
Breaking Hot Stocks news story on InfraREIT 

InfraREIT trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SLB

Schlumberger

$66.53

-0.49 (-0.73%)

08:36
07/24/17
07/24
08:36
07/24/17
08:36
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MED

Medifast

$42.11

0.28 (0.67%)

08:36
07/24/17
07/24
08:36
07/24/17
08:36
Hot Stocks
Medifast: Take Shape For Life rebrands to OPTAVIA »

Medifast announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

P

Pandora

$9.47

0.33 (3.61%)

, AAPL

Apple

$150.27

-0.07 (-0.05%)

08:36
07/24/17
07/24
08:36
07/24/17
08:36
Periodicals
Spotify near new licensing pact with Warner Music, Reuters reports »

Spotify and Warner Music…

P

Pandora

$9.47

0.33 (3.61%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 01

    Aug

  • 08

    Aug

  • 09

    Aug

  • 05

    Sep

HIFR

InfraREIT

$19.90

0.2 (1.02%)

08:35
07/24/17
07/24
08:35
07/24/17
08:35
Hot Stocks
InfraREIT announces agreement regarding dismissal of pending rate case »

InfraREIT announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

DMPI

DelMar Pharmaceuticals

$2.08

0.11 (5.58%)

08:34
07/24/17
07/24
08:34
07/24/17
08:34
Hot Stocks
DelMar Pharmaceuticals: HGRAC approves safety, efficacy study of VAL-083 »

DelMar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

08:34
07/24/17
07/24
08:34
07/24/17
08:34
Conference/Events
Novocure management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 31

    Jul

ALV

Autoliv

$106.78

-9.11 (-7.86%)

08:34
07/24/17
07/24
08:34
07/24/17
08:34
Recommendations
Autoliv analyst commentary  »

Autoliv has reached…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

LMAT

LeMaitre

$28.31

-0.89 (-3.05%)

08:33
07/24/17
07/24
08:33
07/24/17
08:33
Conference/Events
LeMaitre management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 31

    Jul

ARNC

Arconic

$25.21

0.46 (1.86%)

08:33
07/24/17
07/24
08:33
07/24/17
08:33
Earnings
Arconic reports Q2 EPS ex-items 32c, consensus 26c »

Reports Q2 revenue $3.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

WU

Western Union

$19.09

0.01 (0.05%)

, BP

BP

$34.68

-0.42 (-1.20%)

08:33
07/24/17
07/24
08:33
07/24/17
08:33
Hot Stocks
Western Union announces agreement with BP Australia »

The Western Union Company…

WU

Western Union

$19.09

0.01 (0.05%)

BP

BP

$34.68

-0.42 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

GRA

W.R. Grace

$72.17

1.12 (1.58%)

08:33
07/24/17
07/24
08:33
07/24/17
08:33
Conference/Events
W.R. Grace management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 31

    Jul

  • 01

    Aug

PFE

Pfizer

$33.48

-0.06 (-0.18%)

08:32
07/24/17
07/24
08:32
07/24/17
08:32
Hot Stocks
Pfizer says Reflections B7391003 study met primary objective »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 02

    Aug

  • 03

    Aug

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.